70RTAC24FR0000061↗

Name: 70RTAC24FR0000061: Naloxone (Narcan) Nasal Spray 4MG Medication.
Creator: SpendQuery

NALOXONE (NARCAN) NASAL SPRAY 4MG MEDICATION.

Delivery Order · Office of Procurement Operations · to Emergent Devices, Inc. (UEI Q1MZNNSQUJ53) · data as of 2026-09-30

Obligated to date$33.4K1 action

Current value$33.4Kwith options exercised

Potential value$66.9Kif every option is used

Period2024-06-13 → 2025-06-12current end date

What it is

Product or service: Medical- Other (PSC Q999)
Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)
Contracting office: Info Tech Acq Center (70RTAC)
Competition: Full and open competition · 1 offer received
Pricing: Firm fixed price
How it was bought: GSA Schedule · under 36F79723D0188
Solicitation: 70RTAC24Q00000047
Where the work is: District of Columbia, DC · district DC-98
Topics: opioids

Obligations by fiscal year

FY2024$33.4K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2024-06-13. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2024-06-13	0		$33.4K	NALOXONE (NARCAN) NASAL SPRAY 4MG MEDICATION.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗